1378 J. Agric. Food Chem., Vol. 56, No. 4, 2008
Hufnagel and Hofmann
namely, fractions B-1–B-30, which were individually collected into
ice-cooled, brown glass vials. The corresponding effluents obtained from
10 HPLC runs were combined and, after the solvent had been removed
under vacuum, freeze-dried and were directly used for the TDA.
Gel Adsorption Chromatography (GAC). A sample (600 mg) of
content to 100% within 5 min, monitoring the eluent at 272 nm with
a UV–vis detector. After the most active astringent compounds had
been located by means of HPLC degustation, individual peaks were
collected in several runs and the corresponding eluates were combined
and freeze-dried. Spectroscopic data (UV-vis, LC-MS, NMR) of the
taste compounds were identical with those measured for the corre-
sponding reference compounds. Finally, the identity of the taste
compounds as (+)-catechin (HPLC fraction B-10), (-)-epicatechin
(HPLC fraction B-13), procyanidin B1 (HPLC fraction B-10), procya-
nidin B2 (HPLC fraction B-12), procyanidin B3 (HPLC fraction B-1),
and procyanidin C1 (HPLC fraction B-14) was confirmed by cochro-
matography with the reference compounds.
fraction
B
was dissolved in
a
solution of MeOH/water
(20:80, v/v; 10 mL) and placed onto the top of a water-cooled 400 ×
50 mm XK 26/70 glass column (Amersham Pharmacia Biotech,
Uppsala, Sweden) filled with a slurry of Sephadex LH 20 (GE
Healthcare, Munich, Germany), which was conditioned with a solution
of MeOH/water (20:80, v/v) and then adjusted to pH 4 with a 1%
aqueous solution of HCOOH. For chromatography, the column was
eluted sequentially with solutions of MeOH/water containing 20, 40,
60, or 80% MeOH (400 mL each), with MeOH (1200 mL), and finally
with an Me2CO/water (70:30, v/v; pH 4; 800 mL), keeping a flow rate
of 1.3 mL/min by means of a P1-type pump (Pharmacia Biotech). With
the effluent monitored at 272 nm by means of a UV-2575-type UV-vis
detector (Jasco), the GAC fractions were collected every 10 min by
means of an LKB Bromma 7000 Ultrorac fraction collector and
combined to give 13 GAC fractions (I-XIII). The fractions were then
freed from solvent under vacuum, freeze-dried, and used for isolation
and identification of the taste-active compounds located by means of
HPLC/TDA.
Synthesis of Phenolic Acid Ethyl Esters. A solution of caffeic acid,
p-coumaric acid, or syringic acid (15 mmol) in EtOH (100 mL) and
H2SO4 (95%; 0.75 mL) was stirred for 12 h at 60 °C. After cooling,
water (300 mL) was added, the mixture was freed of ethanol under
vacuum, and the remaining aqueous layer was extracted four times with
EtOAc (200 mL each). The combined organic layer was concentrated
under vacuum to about 15 mL, and aliquots (5 mL) were added on top
of a water-cooled glass column (500 × 30 mm) filled with a slurry of
silica gel 60 (6% water) in toluene/EtOAc (60:40, v/v). Chromatography
was performed with toluene/EtOAc (60:40, v/v) with stepwise increas-
ing amounts of EtOAc. Fractions were collected every 150 mL, organic
solvents were removed under vacuum, and the isolates obtained were
analyzed for the target compounds by means of RP-HPLC/DAD, LC-
MS, and NMR spectroscopy.
(+)-Catechin: UV-vis (CH3CN/water, pH 2.5), λmax ) 237, 277;
LC-MS (ESI+), m/z 291 (100; [M + H]+), 598 (35; [M2 + H + H2O]+);
LC-MS (ESI-), m/z 289 (100; [M]-).
(-)-Epicatechin: UV-vis (CH
3CN/water, pH 2.5), λmax ) 237, 277;
LC-MS (ESI+), m/z 291 (100; [M + H]+), 598 (35; [M2 + H + H2O]+);
LC-MS (ESI-), m/z 289 (100; [M]-).
Procyanidin B1: UV-vis (CH3CN/water; pH 2.5), λmax ) 236, 278;
LC-MS (ESI+), m/z 579 (100, [M + 1]+), 601 (39, [2M + Na]+);
LC-MS (ESI-), m/z 577 (100; [M]-).
Procyanidin B2: UV-vis (MeOH/water; pH 2.5), λmax ) 236, 278;
LC-MS (ESI+), m/z 579 (100, [M + 1]+), 601 (39, [2M + Na]+);
LC-MS (ESI-), m/z 577 (100; [M]-).
Procyanidin B3. UV-vis (CH3CN/water; pH 2.5), λmax ) 236, 277;
LC-MS (ESI+), m/z 579 (100, [M + 1]+), 601 (40, [2M + Na]+);
LC-MS (ESI-), m/z 577 (100; [M]-).
Procyanidin C1: UV-vis (CH3CN/water; pH 2.5), λmax ) 236, 278;
LC-MS (ESI+), m/z 867 (100, [M + 1]+), 889 (45, [M + Na]+); LC-
MS (ESI-), m/z 865 (100; [M]-).
Identification of Flavon-3-ol- and Dihydroflavon-3-ol Glycosides.
Analytical HPLC analysis of the GAC fractions revealed that the taste
compounds detected in HPLC fractions B-19, B-21, B-23, and B-25
by means of HPLC/TDA were present in GAC fractions VII and VIII.
Preparative HPLC, followed by UV-vis, LC-MS/MS, and 1D/2D NMR
spectroscopy led to the identification of the key astringent compounds
as quercetin-3-O-ꢀ-D-galactopyranoside (B-19), 2R,3R-dihydroquerce-
tin-3-O-R-L-rhamnoside (B-21), 2R,3R-dihydrokaempferol-3-O-R-L-
rhamnoside (B-23), quercetin-3-O-ꢀ-D-glucuropyranoside (B-21), isor-
hamnetin-3-O-ꢀ-D-glucopyranoside (B-23), and syringetin-3-O-ꢀ-D-
glucopyranoside (B-25) in the HPLC fractions given in parentheses.
The latter three substances were confirmed by cochromatography with
the corresponding reference compound.
Quercetin-3-O-ꢀ-D-galactopyranoside: UV-vis (CH3CN/water; pH
2.5), λmax ) 215, 251, 355; LC-MS (ESI+), m/z 465 (100; [M + 1]+),
303 (53; [M - gal + 1]+); 1H and 13C NMR data were identical with
those measured for the reference compound.
Isorhamnetin-3-O-ꢀ-D-glucopyranoside: UV-vis (CH3CN/water; pH
2.5), λmax ) 254, 350; LC-MS (ESI+), m/z 479 (100; [M + 1]+), 317
(45; [M - glc + 1]+); 1H and 13C NMR data were identical with those
measured for the reference compound.
Caffeic acid ethyl ester: UV-vis (CH3CN/water; pH 2.5), λmax
)
241, 297, 323; LC-MS (ESI+), m/z 209 (100; [M + 1]+), 163 (53; [M
1
- C2H5 - H2O + 1]+), 181 (20; [M - C2H5 + 1]+); H NMR (400
MHz; CD3OD), δ 1.36 [t, 3H, H-C(2′)], 4.23 [dd, 2H, H-C(1′)], 6.26
[d, 1H, H-C(2)], 6.79 [d, 1H, H-C(8)], 6.96 [dd, 1H, H-C(9)], 7.05 [d,
1H, H-C(5)], 7.55 [d, 1H, H-C(3)]; 13C NMR (100 MHz; CD3COD),
δ 13.3 [C(2′)], 60.1 [C(1′)], 113.6 [C(5)], 113.9 [C(2)], 115.0 [C(8)],
121.5 [C(9)], 126,4 [C(4)], 145.3 [C(3)], 145.4 [C(7)], 148.1 [C(6)],
176.9 [C(1)].
p-Coumaric acid ethyl ester: UV-vis (CH3CN/water; pH 2.5), λmax
) 234, 323; LC-MS (ESI+), m/z 193 (100; [M + 1]+), 147 (53; [M -
C2H5 - H2) + 1]+), 165 (21; [M - C2H5 + 1]+); 1H NMR (400 MHz;
CD3OD), δ 1.35 [t, 3H, H-C(2′)], 4.23 [dd, 2H, H-C(1′)], 6.33 [d, 1H,
H-C(2)], 6.82 [d, 2H, H-C(6), H-C(8)], 7.47 [d, 2H, H-C(5), H-C(9)],
7.62 [d, 1H, H-C(3)]; 13C NMR (100 MHz; CD3COD), δ 13.2 [C(2′)],
60.0 [C(1′)], 113.9 [C(2)], 115.4 [C(6), C(8)], 125.8 [C)4)], 129.7 [C(5),
C(9)], 144.9 [C(3)], 159.9 [C(7)], 167.9 [C(1)].
Syringetin-3-O-ꢀ-D-glucopyranoside: UV-vis (CH3CN/water; pH
2.5), λmax ) 252, 355; LC-MS (ESI+), m/z 509 (100; [M + 1]+), 523
1
(60; [M + Na]+), 347 (20; [M - glc + 1]+); H and 13C NMR data
Syringic acid ethyl ester: UV-vis (CH3CN/water; pH 2.5), λmax
)
were identical with those measured for the reference compound.
Quercetin-3-O-ꢀ-D-glucuropyranoside: UV-vis (CH3CN/water; pH
2.5), λmax ) 255, 350; LC-MS (ESI-), m/z 477 (100; [M - 1]-), 301
(20; [M - glu - 1]-); 1H NMR (400 MHz; CD3COD), δ 3.46 [m,
1H, H-C(3′′)], 3.53 [m, 1H, H-C(2′′)], 3.58 [dd, 1H, H-C(4′′)], 3.74
[d, 1H, H-C(5′′)], 5.34 [d, J ) 7.6 Hz 1H, H-C(1′′)], 6.20 [d, 1H,
H-C(6)], 6.39 [d, 1H, H-C(8)], 6.84 [d, 1H, H-C(5′)], 7.62 [dd, 1H,
H-C(6′)], 7.64 [d, 1H, H-C(2′)]; 13C NMR (100 MHz; CD3COD), δ
71.7 [C(4′′)], 74.2 [C(2′′)], 75.9 [C(5′′)], 76.4 [C(3′′)], 93.5 [C(8)], 98.7
[C(6)], 103.1 [C(1′′)], 104.5 [C(10)], 114.5 [C(5′)], 116.0 [C(2′)], 121.7
[C(1′)], 122.3 [C(6′)], 134.2 [C(3)], 144.8 [C(3′)], 148.7 [C(4′)], 157.2
[C(9)], 157.9 [C(2)], 161.9 [C(5)], 164.8 [C(7)], 171.2 [C(6′′)], 178.1
[C(4)].
275; LC-MS (ESI+), m/z 227 (100; [M + 1]+), 199 (28; [M - C2H5
+ 1]+); 1H NMR (400 MHz; DMSO-d6), δ 1.31 [t, 3H, H-C(2′)], 3.81
[s, 6H, H-C(1′′), H-C(2′′)], 4.28 [dd, 2H, H-C(1′)], 7.21 [s, 2H, H-C(3),
H-C(7)]; 13C NMR (100 MHz; DMSO), δ 14.8 [C(2′)], 56.5 [C(1′′),
C(2′′)], 60.9 [C(1′)], 107.1 [C(3), C(7)], 119.9 [C(2)], 141.0 [C(5)],
147.9 [C(4), C(6)], 166.0 [C(1)].
Identification of Flavan-3-ols. Analytical HPLC analysis of the
GAC fractions revealed that the taste compounds detected in HPLC
fractions B-12 and B-14 by means of HPLC/TDA were present in GAC
fractions X and XI. Samples (200 mg) of the individual fractions were
dissolved in 1% aqueous HCOOH (20 mL), and after membrane
filtration, aliquots (2 mL) of the solution were used for preparative
RP-HPLC. The chromatographic column was eluted consecutively with
a solution of 1% aqueous HCOOH and CH3CN (95:5, v/v), then
increasing the CH3CN content to 17% within 35 min, keeping the
CH3CN content constant for 15 min, thereafter increasing the CH3CN
2R,3R-Dihydrokaempferol-3-O-R-L-rhamnoside, engelitin: UV-vis
(CH3CN), λmax ) 290; LC-MS (ESI+), m/z 435 (19; [M + 1]+), 457
(100; [M + Na]+), 311 (10; [M - rha + Na]+), 289 (5; [M - rha +
1
1]+); H NMR (400 MHz; CD3COD), δ 1.09 [d, 3H, H-C(6′′)], 3.26